Publications

Nuclear Imaging of Bispecific Antibodies on the Rise.
Roohani B, Mendez AS, Dangarwala M, Katz S, Marquez-Nostra B.J Nucl Med. 2024 Oct 1;65(10):1512-1517. doi: 10.2967/jnumed.123.267215.PMID: 39266295 Review.

Melanocortin-1 Receptor Expression as a Marker of Progression in Melanoma.
Su DG, Djureinovic D, Schoenfeld D, Marquez-Nostra B, Olino K, Jilaveanu L, Kluger H.JCO Precis Oncol. 2024 Apr;8:e2300702. doi: 10.1200/PO.23.00702.PMID: 38662983

Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastoma.
Khang M, Lee JH, Lee T, Suh HW, Lee S, Cavaliere A, Rushing A, Geraldo LH, Belitzky E, Rossano S, de Feyter HM, Shin K, Huttner A, Roussel MF, Thomas JL, Carson RE, Marquez-Nostra B, Bindra RS, Saltzman WM.Sci Transl Med. 2023 Nov;15(720):eadi1617. doi: 10.1126/scitranslmed.adi1617. Epub 2023 Nov 1.PMID: 37910601 Free PMC article.

Melanocortin 1 receptor (MC1R) expression as a marker of progression in melanoma.
Su D, Djureinovic D, Schoenfeld D, Marquez-Nostra B, Olino K, Jilaveanu L, Kluger H.Res Sq [Preprint]. 2023 Sep 19:rs.3.rs-3314825. doi: 10.21203/rs.3.rs-3314825/v1.Update in: JCO Precis Oncol. 2024 Apr;8:e2300702. doi: 10.1200/PO.23.00702.PMID: 37790306 Free PMC article. Preprint.

Systematic Literature Review of Machine Learning Algorithms Using Pretherapy Radiologic Imaging for Glioma Molecular Subtype Prediction.
Lost J, Verma T, Jekel L, von Reppert M, Tillmanns N, Merkaj S, Petersen GC, Bahar R, Gordem A, Haider MA, Subramanian H, Brim W, Ikuta I, Omuro A, Conte GM, Marquez-Nostra BV, Avesta A, Bousabarah K, Nabavizadeh A, Kazerooni AF, Aneja S, Bakas S, Lin M, Sabel M, Aboian M.AJNR Am J Neuroradiol. 2023 Oct;44(10):1126-1134. doi: 10.3174/ajnr.A8000.PMID: 37770204 Free PMC article.

ImmunoPET Imaging Identifies the Optimal Timepoint for Combination Therapy in Xenograft Models of Triple-Negative Breast Cancer.
Li Z, Belitzky E, Blaha O, Cavaliere A, Katz SR, Aboian M, Melegari L, Rajabimoghadam K, Kurpiewski S, Zhu X, Marquez-Nostra B.Cancers (Basel). 2023 Mar 3;15(5):1589. doi: 10.3390/cancers15051589.PMID: 36900378 Free PMC article.

Determining Binding Affinity (KD) of Radiolabeled Antibodies to Immobilized Antigens.
Belitzky E, Cavaliere A, Rajabimoghadam K, Marquez-Nostra B.J Vis Exp. 2022 Jun 23;(184). doi: 10.3791/63927.PMID: 35815982

PET Imaging in Animal Models of Alzheimer’s Disease.
Chen B, Marquez-Nostra B, Belitzky E, Toyonaga T, Tong J, Huang Y, Cai Z.Front Neurosci. 2022 May 24;16:872509. doi: 10.3389/fnins.2022.872509. eCollection 2022.PMID: 35685772 Free PMC article. Review.

Clinical Evaluation of Nuclear Imaging Agents in Breast Cancer.
Li Z, Aboian MS, Zhu X, Marquez-Nostra B.Cancers (Basel). 2022 Apr 23;14(9):2103. doi: 10.3390/cancers14092103.PMID: 35565232 Free PMC article. Review.

[89Zr]ZrDFO-CR011 PET Correlates with Response to Glycoprotein Nonmetastatic Melanoma B-targeted Therapy in Triple-negative Breast Cancer.
Lee S, Cavaliere A, Gallezot JD, Keler T, Michelhaugh SK, Belitzky E, Liu M, Mulnix T, Maher SE, Bothwell ALM, Li F, Phadke M, Mittal S, Marquez-Nostra B.Mol Cancer Ther. 2022 Mar 1;21(3):440-447. doi: 10.1158/1535-7163.MCT-21-0590.PMID: 35027482 Free PMC article.

Preclinical Advances in Theranostics for the Different Molecular Subtypes of Breast Cancer.
Fang H, Cavaliere A, Li Z, Huang Y, Marquez-Nostra B.Front Pharmacol. 2021 Apr 27;12:627693. doi: 10.3389/fphar.2021.627693. eCollection 2021.PMID: 33986665 Free PMC article. Review.

Development of [89Zr]ZrDFO-amivantamab bispecific to EGFR and c-MET for PET imaging of triple-negative breast cancer.
Cavaliere A, Sun S, Lee S, Bodner J, Li Z, Huang Y, Moores SL, Marquez-Nostra B.Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):383-394. doi: 10.1007/s00259-020-04978-6. Epub 2020 Aug 8.PMID: 32770372 Free PMC article.